Mesothelioma
Results
Phase 3
This trial looked at a drug called vorinostat (also known as MK0683) for mesothelioma of the lung that continued to grow despite having chemotherapy.
The results of this trial were published in 2015.
Recruitment start: 16 January 2006
Recruitment end: 31 January 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Robinson
Experimental Cancer Medicine Centre (ECMC)
Merck Sharp & Dohme Ltd
Last reviewed: 21 March 2018
CRUK internal database number: 1517
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
